Switching From Aflibercept 2 mg to 8 mg in Vitrectomized Eyes With Neovascular Age-Related Macular Degeneration.
Saved in:
| Title: | Switching From Aflibercept 2 mg to 8 mg in Vitrectomized Eyes With Neovascular Age-Related Macular Degeneration. |
|---|---|
| Authors: | Tamai R; Department of Ophthalmology and Visual Science, Chiba University Graduate School of Medicine, Chiba, JPN.; Department of Ophthalmology, Chiba Rosai Hospital, Chiba, JPN., Nizawa T; Department of Ophthalmology and Visual Science, Chiba University Graduate School of Medicine, Chiba, JPN., Kawamata Y; Department of Ophthalmology and Visual Science, Chiba University Graduate School of Medicine, Chiba, JPN., Iwase T; Department of Ophthalmology and Visual Science, Chiba University Graduate School of Medicine, Chiba, JPN., Baba T; Department of Ophthalmology and Visual Science, Chiba University Graduate School of Medicine, Chiba, JPN. |
| Source: | Cureus [Cureus] 2025 Oct 01; Vol. 17 (10), pp. e93645. Date of Electronic Publication: 2025 Oct 01 (Print Publication: 2025). |
| Publication Type: | Case Reports; Journal Article |
| Journal Info: | Publisher: Cureus, Inc Country of Publication: United States NLM ID: 101596737 Publication Model: eCollection Cited Medium: Print ISSN: 2168-8184 (Print) Linking ISSN: 21688184 NLM ISO Abbreviation: Cureus Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
